Suppr超能文献

常见可变免疫缺陷中血清BAFF、APRIL和TACI水平升高。

High serum levels of BAFF, APRIL, and TACI in common variable immunodeficiency.

作者信息

Knight Adina K, Radigan Lin, Marron Thomas, Langs Allison, Zhang Li, Cunningham-Rundles Charlotte

机构信息

Department of Medicine, Mount Sinai Medical Center, 1425 Madison Avenue, New York City, NY 10029, USA.

出版信息

Clin Immunol. 2007 Aug;124(2):182-9. doi: 10.1016/j.clim.2007.04.012. Epub 2007 Jun 7.

Abstract

Common variable immunodeficiency (CVID) is characterized by low levels of immune globulins and lack of antibody. Mutations in transmembrane activator and calcium-modulating cyclophilin ligand (TACI), are found in 8-10%, associated with autoimmunity and splenomegaly. Some patients with mutations had increased serum levels of TACI. Because of this, and the prevalence of autoimmunity, splenomegaly, and lymphadenopathy, we quantitated levels of TACI ligands, a proliferation inducing ligand (APRIL) and B cell activating factor (BAFF) and TACI in serum of 77 patients. CVID subjects had markedly increased serum levels of BAFF (p<0.0001), APRIL (p<0.0001), and TACI (p=0.001) but there was no relationship between levels and autoimmunity, lymphadenopathy, splenomegaly, B cell numbers, or mutations in TACI. Peripheral blood mononuclear cells of CVID subjects had increased levels of BAFF mRNA. We conclude that increased constitutive production and/or underlying immuno-regulatory or inflammatory conditions lead to enhanced release of ligands; however, the biological result remains unclear.

摘要

普通可变免疫缺陷(CVID)的特征是免疫球蛋白水平低和缺乏抗体。跨膜激活剂和钙调节亲环素配体(TACI)的突变在8%-10%的患者中被发现,与自身免疫和脾肿大有关。一些有突变的患者血清中TACI水平升高。因此,鉴于自身免疫、脾肿大和淋巴结病的普遍性,我们对77例患者血清中的TACI配体、增殖诱导配体(APRIL)、B细胞活化因子(BAFF)和TACI水平进行了定量。CVID患者血清中BAFF(p<0.0001)、APRIL(p<0.0001)和TACI(p=0.001)水平显著升高,但这些水平与自身免疫、淋巴结病、脾肿大、B细胞数量或TACI突变之间没有关系。CVID患者外周血单个核细胞中BAFF mRNA水平升高。我们得出结论,组成性产生增加和/或潜在的免疫调节或炎症状态导致配体释放增加;然而,生物学结果仍不清楚。

相似文献

1
High serum levels of BAFF, APRIL, and TACI in common variable immunodeficiency.
Clin Immunol. 2007 Aug;124(2):182-9. doi: 10.1016/j.clim.2007.04.012. Epub 2007 Jun 7.
2
Reduced BAFF-R and increased TACI expression in common variable immunodeficiency.
J Clin Immunol. 2014 Jul;34(5):573-83. doi: 10.1007/s10875-014-0047-y. Epub 2014 May 9.
3
Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency.
Curr Opin Allergy Clin Immunol. 2008 Dec;8(6):520-6. doi: 10.1097/ACI.0b013e3283141200.
6
TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotes.
J Allergy Clin Immunol. 2013 Feb;131(2):468-76. doi: 10.1016/j.jaci.2012.10.029. Epub 2012 Dec 11.
8
TACI expression and signaling in chronic lymphocytic leukemia.
J Immunol Res. 2015;2015:478753. doi: 10.1155/2015/478753. Epub 2015 Apr 9.
10
CVID-associated TACI mutations affect autoreactive B cell selection and activation.
J Clin Invest. 2013 Oct;123(10):4283-93. doi: 10.1172/JCI69854. Epub 2013 Sep 24.

引用本文的文献

2
Primary versus Secondary Immune Thrombocytopenia (ITP): A Meeting Report from the 2023 McMaster ITP Summit.
Thromb Haemost. 2025 Sep;125(9):923-932. doi: 10.1055/a-2508-1112. Epub 2024 Dec 24.
4
B cells and the coordination of immune checkpoint inhibitor response in patients with solid tumors.
J Immunother Cancer. 2024 Apr 16;12(4):e008636. doi: 10.1136/jitc-2023-008636.
6
Lymphoid stromal cells - potential implications for the pathogenesis of CVID.
Front Immunol. 2023 Feb 17;14:1122905. doi: 10.3389/fimmu.2023.1122905. eCollection 2023.
7
Seeking Relevant Biomarkers in Common Variable Immunodeficiency.
Front Immunol. 2022 Mar 11;13:857050. doi: 10.3389/fimmu.2022.857050. eCollection 2022.
8
Shared Pathogenetic Features Between Common Variable Immunodeficiency and Sjögren's Syndrome: Clues for a Personalized Medicine.
Front Immunol. 2021 Jul 12;12:703780. doi: 10.3389/fimmu.2021.703780. eCollection 2021.
9
Approaches for Controlling Antibody-Mediated Allograft Rejection Through Targeting B Cells.
Front Immunol. 2021 Jul 1;12:682334. doi: 10.3389/fimmu.2021.682334. eCollection 2021.
10
Lymphoid malignancy in common variable immunodeficiency in a single-center cohort.
Eur J Haematol. 2021 Nov;107(5):503-516. doi: 10.1111/ejh.13687. Epub 2021 Aug 6.

本文引用的文献

1
High-level serum B-cell activating factor and promoter polymorphisms in patients with idiopathic thrombocytopenic purpura.
Br J Haematol. 2007 Jan;136(2):309-14. doi: 10.1111/j.1365-2141.2006.06431.x. Epub 2006 Nov 30.
2
B-cell-targeted therapy for systemic lupus erythematosus.
Drugs. 2006;66(15):1933-48. doi: 10.2165/00003495-200666150-00004.
7
BAFF, APRIL and human B cell disorders.
Semin Immunol. 2006 Oct;18(5):305-17. doi: 10.1016/j.smim.2006.04.004. Epub 2006 Aug 17.
8
Role of BAFF and APRIL in human B-cell chronic lymphocytic leukaemia.
Immunology. 2006 Jul;118(3):281-92. doi: 10.1111/j.1365-2567.2006.02377.x.
9
An antibody-deficiency syndrome due to mutations in the CD19 gene.
N Engl J Med. 2006 May 4;354(18):1901-12. doi: 10.1056/NEJMoa051568.
10
TLR9 activation is defective in common variable immune deficiency.
J Immunol. 2006 Feb 1;176(3):1978-87. doi: 10.4049/jimmunol.176.3.1978.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验